RxDoctor Payments Data

Anthony Yeung

Phoenix, AZNPI 1821034356

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $16,722,074 of the $16,762,553 with a category attached, or 99.8%. Stryker accounts for 99.8% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $16,722,454 and has fallen 100.0% since, to $1,972 in 2024.

$16,762,553in general payments, 2019–2025

Across 61 payments — averaging $274,796 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$16.7M
  • Richard Wolf Medical Instruments Corp.$36K
  • Arthrex$2K
  • Aesculap, Inc.$1K
  • Surgalign Spine Technologies, Inc.$562
  • Integrity Implants Inc. Dba Accelus$304
  • plus $587 from 8 others

What the payments were for

  • Royalty or licence$5620%
  • Speaking & faculty fees$16,722,074100%
  • Travel & lodging$8550%
  • Food & beverage$1,6290%
  • Education$36,3780%
  • Gifts$1,0550%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →